8-K current report · filed Nov 12, 2026

ALUMIS INC. (ALMS) 8-K Current Report: November 12, 2026

Item 2.02Item EX-99.1ALMS overview

Short answer

ALUMIS INC. (ALMS) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Press release covers Alumis fiscal quarter ended September 30, 2026.

ALUMIS INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release covers Alumis fiscal quarter ended September 30, 2026
  • Exhibit 99.1 contains the company’s financial results and accompanying management disclosures
  • Investor focus: quarterly performance details, cash position, and forward outlook in the attached release

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $1.9M versus $2.1M, while net loss improved to $94.9M from $110.8M
  • Cash, equivalents and marketable securities $431.3M, supporting operations and capital needs into Q4 2027
  • Envudeucitinib psoriasis data showed 54% PASI 100 response at Week 48, with NDA submission still targeted for Q4 2026
  • LUMUS missed primary and secondary endpoints overall in SLE, though IFNGS-high subgroup responses support regulatory discussions
  • R&D spending fell to $80.8M from $97.8M as pivotal psoriasis trials progressed, partially offset by ONWARD3 costs

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ALUMIS INC. 8-K filings

Get the next ALMS 8-K as it lands

Follow ALMS for push alerts, or ask the research agent what this filing means.